GH Research is trading 7.14% down at $25.90 in after-hours trading after closing at $27.89 on September 14, 2026, with no clear company-specific catalyst.
- Available company disclosures show no new September 14 announcement; the latest notable item was planned investor meetings at the Morgan Stanley Global Healthcare Conference from September 14–16.
- The broader market was modestly weaker, but S&P 500, Nasdaq, and Dow declines were below 0.5%; the decline remains unexplained and may warrant rechecking for delayed news.